Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Integragen

ALINT
Current price
0.5 EUR -0.015 EUR (-2.91%)
Last closed 0.52 EUR
ISIN FR0010908723
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 3 438 867 EUR
Yield for 12 month -50.00 %
1Y
3Y
5Y
10Y
15Y
ALINT
21.11.2021 - 28.11.2021

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA. Address: Genopole Campus 1 BAt. 8, Évry, France, 91000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.62 EUR

P/E ratio

Dividend Yield

Current Year

+12 659 282 EUR

Last Year

+13 294 725 EUR

Current Quarter

+4 614 415 EUR

Last Quarter

+6 546 923 EUR

Current Year

-7 046 EUR

Last Year

-6 417 EUR

Current Quarter

-685 599 EUR

Last Quarter

+2 723 316 EUR

Key Figures ALINT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 233 307 EUR
Operating Margin TTM 6.54 %
PE Ratio
Return On Assets TTM 0.24 %
PEG Ratio
Return On Equity TTM -8.17 %
Wall Street Target Price 3.62 EUR
Revenue TTM 12 726 081 EUR
Book Value 0.31 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 1 %
Dividend Yield
Gross Profit TTM 11 434 055 EUR
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -34.2 %
Profit Margin -1.36 %

Dividend Analytics ALINT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALINT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALINT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.1469
Price Sales TTM 0.2702
Enterprise Value EBITDA -11.658
Price Book MRQ 1.677

Financials ALINT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALINT

For 52 weeks

0.47 EUR 1.06 EUR
50 Day MA 0.54 EUR
Shares Short Prior Month
200 Day MA 0.64 EUR
Short Ratio
Shares Short
Short Percent